Comfort food: Probiotic-derived product protects in model of intestinal inflammation

May 23, 2011, Journal of Clinical Investigation

Many people tout the beneficial effects of probiotics in preventing and/or treating several intestinal diseases, including ulcerative colitis.

Although there have been few, if any, good clinical studies evaluating the clinical efficacy of probiotics, preclinical data suggest that probiotics and approaches utilizing probiotic-derived products could be effective therapies for acute and chronic .

In this context, a team of researchers, led by Fang Yan, at Vanderbilt University Medical Center, Nashville, have now identified a new –derived soluble protein that can protect intestinal cells from inflammation and injury and unraveled its mechanism of action. Importantly, specific delivery of the protein (p40) to the colon provided therapeutic and prophylactic protection in several mouse models of colitis. The authors suggest that their data provide rationale for the development of probiotic-derived proteins as reagents for preventing and/or treating ulcerative intestinal inflammatory disorders.

In an accompanying commentary, Fayez Ghishan and Pawel Kiela, at the University of Arizona, Tucson, concur with this position, although they caution that further work in humans is needed.

Explore further: Protein from probiotic bacteria may alleviate inflammatory bowel disorders

More information: Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism, www.jci.org/articles/view/4403 … 24d663bbebde11d8c23d

From probiotics to therapeutics: another step forward? www.jci.org/articles/view/5802 … 9172d5ef2e96a5eda4f0

Related Stories

Protein from probiotic bacteria may alleviate inflammatory bowel disorders

May 23, 2011
A protein isolated from beneficial bacteria found in yogurt and dairy products could offer a new, oral therapeutic option for inflammatory bowel disorders (IBD), suggests a study led by Vanderbilt University Medical Center ...

Recommended for you

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.